14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo]

RxCUI: 1539891
RxNorm name: 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo]
Display name: 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo]
Full name: 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Breo Ellipta	FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE	GlaxoSmithKline LLC	96428df1-ea05-431a-98d3-1ec2c4b63878	2024-11-07	Warnings, Adverse reactions	Exact identifier rxcui: 1539891

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
96428df1-ea05-431a-98d3-1ec2c4b63878	Breo Ellipta 100/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters [PSN] · 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] [SBD] · Breo Ellipta (fluticasone furoate 100 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT [SY] · Breo Ellipta (fluticasone furoate 100 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT [SY] · Breo Ellipta Institutional Pack [SY]	5	28	These highlights do not include all the information needed to use BREO ELLIPTA safely and effectively. See full prescribing information for BREO ELLIPTA. BREO ELLIPTA (fluticasone furoate and vilanterol inhalation powder), for oral inhalation use Initial U.S. Approval: 2013	20241107